Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
TORONTO, ONTARIO--(Marketwired - Nov. 25, 2014) - African Gold Group, Inc. (TSX VENTURE:AGG) ("African Gold Group" or the "Company") is pleased to announce the completion of a Scoping...
-
NEW YORK and MELBOURNE, Australia, Nov. 24, 2014 (GLOBE NEWSWIRE) -- Mesoblast Limited (ASX:MSB) (USOTC:MBLTY) provided an update to the market on the Pharmaceuticals, Medical Devices and Other...
-
SAN DIEGO, Nov. 20, 2014 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX:RVA) ("REVA" or the "Company") is pleased to announce that the financing transaction approved by the Company's shareholders at the...
-
ADELAIDE, Australia, Nov. 20, 2014 (GLOBE NEWSWIRE) -- Bionomics Limited (ASX:BNO) (ADR:BMICY) is presenting a poster on cancer stem cell antibody BNC101 at the 26th EORTC-NCI-AACR Symposium on...
-
SAN DIEGO, Calif., Nov. 20, 2014 (GLOBE NEWSWIRE) -- via PRWEB - Visage Imaging Inc. ("Visage"), a wholly owned subsidiary of Pro Medicus Ltd. (ASX: PME), announced today that WellSpan Health...
-
ADELAIDE, Australia, Nov. 17, 2014 (GLOBE NEWSWIRE) -- Bionomics Limited (ASX:BNO) (ADR:BMICY) is presenting a poster on anti-anxiety compound BNC210 at the Neuroscience 2014 conference being held by...
-
NEW YORK and MELBOURNE, Australia, Nov. 12, 2014 (GLOBE NEWSWIRE) -- Mesoblast's Phase 2 trial results in degenerative disc disease were presented today at the North American Spine Society (NASS)...
-
SAN DIEGO, Calif., Nov. 11, 2014 (GLOBE NEWSWIRE) -- via PRWEB - Visage Imaging Inc. ("Visage"), a wholly owned subsidiary of Pro Medicus Ltd. (ASX: PME), announced today that the latest release of...
-
Bionomics to accelerate BNC210 development for the treatment of anxiety and depression, approval for clinical trial granted Bionomics has re-acquired sole worldwide rights to develop and...
-
SAN DIEGO, Nov. 5, 2014 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX:RVA) ("REVA" or the "Company") will hold a conference call to provide an update on the Company's operations and its business...